Dermatomyositis: severe acute respiratory syndrome coronavirus 2, an initiator or a trigger?
Journal of the Egyptian Women's Dermatologic Society
; 20(1):52-56, 2023.
Article
in English
| EMBASE | ID: covidwho-2236013
ABSTRACT
Dermatomyositis is an immune-mediated inflammatory myopathy. In adults, the common triggering factors for its onset include viral infections, malignancy, and drugs. The clinical manifestation of these group of disorders may be cutaneous, neurological, pulmonary, or a combination of all. The cutaneous manifestations are helpful in the early clinical diagnosis. The detection of myositis-specific autoantibodies serves as specific biomarkers for the diagnosis and helps in predicting the prognosis. We are presenting two cases of dermatomyositis, temporally related to the severe acute respiratory syndrome coronavirus 2 infection and vaccination. Copyright © 2022 Journal of the Egyptian Women's Dermatologic Society.
coronavirus disease 2019; dermatomyositis; myositis; adult; aged; article; back; bronchiectasis; case report; clinical article; clinical feature; computer assisted tomography; coronavirus disease 2019/dt [Drug Therapy]; coronavirus disease 2019/pc [Prevention]; dermatomyositis/co [Complication]; dermatomyositis/di [Diagnosis]; dermatomyositis/dt [Drug Therapy]; dermatomyositis/et [Etiology]; dermatomyositis/si [Side Effect]; diabetes mellitus; erosion; erythema; eye swelling; eyelid; face; female; follow up; ground glass opacity; human; hyperpigmentation; hypertension; long COVID/co [Complication]; long COVID/di [Diagnosis]; long COVID/et [Etiology]; middle aged; nape; neck; nonhuman; periorbital edema/si [Side Effect]; poikiloderma; scalp; Severe acute respiratory syndrome coronavirus 2; shoulder; skin defect; skin pruritus; skin ulcer; thigh; vaccination; weakness; amlodipine/pv [Special Situation for Pharmacovigilance]; autoantibody/ec [Endogenous Compound]; glimepiride/pv [Special Situation for Pharmacovigilance]; hydroxychloroquine/dt [Drug Therapy]; interferon induced helicase C domain containing protein 1; methylprednisolone/iv [Intravenous Drug Administration]; methylprednisolone/pv [Special Situation for Pharmacovigilance]; mycophenolate mofetil/po [Oral Drug Administration]; mycophenolate mofetil/pv [Special Situation for Pharmacovigilance]; vaxzevria/ae [Adverse Drug Reaction]; vaxzevria/dt [Drug Therapy]
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Prognostic study
Topics:
Vaccines
Language:
English
Journal:
Journal of the Egyptian Women's Dermatologic Society
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS